Publication:
Comparison of Renal and Metabolic Effects of Empagliflozin and Dapagliflozin on Type 2 Diabetes-Induced Rats

Simple item page
dc.contributor.authorHerdan, Nadir Emre
dc.contributor.authorGürsu, Meltem
dc.contributor.authorÇoban, Ganime
dc.contributor.authorSelek, Şahabettin
dc.contributor.authorKazancıoğlu, Rümeyza
dc.contributor.institutionauthorGÜRSU, MELTEM
dc.contributor.institutionauthorÇOBAN, GANİME
dc.contributor.institutionauthorSELEK, ŞAHABETTİN
dc.contributor.institutionauthorKAZANCIOĞLU, RÜMEYZA
dc.date.accessioned2022-10-15T20:59:05Z
dc.date.available2022-10-15T20:59:05Z
dc.date.issued2022-10-15T00:00:00Z
dc.identifier.urihttp://hdl.handle.net/20.500.12645/31118
dc.subjectHerdan N. E. , Gürsu M., Çoban G., Selek Ş., Kazancıoğlu R., -Comparison of Renal and Metabolic Effects of Empagliflozin and Dapagliflozin on Type 2 Diabetes-Induced Rats-, American Society of Nephrology /Kidney Week 2022, California, Amerika Birleşik Devletleri, 3 - 06 Kasım 2022, ss.663
dc.titleComparison of Renal and Metabolic Effects of Empagliflozin and Dapagliflozin on Type 2 Diabetes-Induced Rats
dc.typeConference Paper
dspace.entity.typePublication
local.avesis.id8b7d6d22-6751-45bf-a8d0-0bdd9d61a49c
local.publication.isinternational1
relation.isAuthorOfPublicationa6446eac-0ccd-4457-9227-3fc72dec68d1
relation.isAuthorOfPublication92813154-621b-468c-8399-8510ae43f718
relation.isAuthorOfPublication8eb7d539-8ea4-435c-830e-8ef630342c7d
relation.isAuthorOfPublicationeca7bd30-6b6e-444d-96ae-2961c39f2107
relation.isAuthorOfPublication.latestForDiscovery8eb7d539-8ea4-435c-830e-8ef630342c7d

Files

Collections

Yayınlar - Eserler